GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PainReform Ltd (NAS:PRFX) » Definitions » Beginning Cash Position

PainReform (PainReform) Beginning Cash Position : $8.04 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is PainReform Beginning Cash Position?

PainReform's Beginning Cash Position for the quarter that ended in Mar. 2024 was $8.04 Mil.

PainReform's quarterly Beginning Cash Position declined from Sep. 2023 ($8.74 Mil) to Dec. 2023 ($8.58 Mil) and declined from Dec. 2023 ($8.58 Mil) to Mar. 2024 ($8.04 Mil).

PainReform's annual Beginning Cash Position increased from Dec. 2021 ($15.69 Mil) to Dec. 2022 ($16.57 Mil) but then declined from Dec. 2022 ($16.57 Mil) to Dec. 2023 ($4.11 Mil).

PainReform Beginning Cash Position Historical Data

The historical data trend for PainReform's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PainReform Beginning Cash Position Chart

PainReform Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial 0.05 0.95 15.69 16.57 4.11

PainReform Quarterly Data
Dec18 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.11 8.15 8.74 8.58 8.04

PainReform Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

PainReform Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of PainReform's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

PainReform (PainReform) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PainReform Ltd (NAS:PRFX) » Definitions » Beginning Cash Position
Comparable Companies
AGRX OWPC JUVAF CLVR STEK KOAN EVOK UPC PTPI CNNC ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
65 Yigal Alon Street, Tel Aviv, ISR, 6744316
Website
https://www.painreform.com
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.